University of Massachusetts Medical School Faculty Publications

UMMS Affiliation

Division of Preventive and Behavioral Medicine, Department of Medicine

Date

5-1-2016

Document Type

Article

Disciplines

Dermatology | Health Policy | Public Health

Abstract

Tanning bed use, particularly among teen girls and young adult women, has become a modern-day epidemic in the past 20 years. Numerous studies have established the link between indoor tanning use and skin cancer, including melanoma. Reducing the harms of indoor tanning is one of 5 goals outlined in the 2014 US Surgeon General’s “Call to Action to Prevent Skin Cancer.”Consistent with the Call to Action, on December 22, 2015, the US Food and Drug Administration (FDA) issued a proposed rule with the following restrictions for sunlamp products (ie, indoor tanning beds and booths): (1) to ban their use among individuals younger than 18 years; (2) to require prospective users to sign a risk acknowledgment certification; and (3) to provide user manuals to customers and tanning facility operators on request.

Rights and Permissions

Publisher PDF posted after 12 months as allowed by the publisher's author rights policy at http://jamanetwork.com/journals/jamadermatology/pages/instructions-for-authors#SecDepositingResearchArticlesinApprovedPublicRepositories. Citation: JAMA Dermatol. 2016 May 1;152(5):509-10. doi: 10.1001/jamadermatol.2016.0504. Link to article on publisher's site

Related Resources

Link to Article in PubMed

Keywords

indoor tanning, FDA, regulation

PubMed ID

26981925

Available for download on Monday, May 01, 2017

Share

COinS